HB 1381: Experimental Treatments for Terminal Conditions and Life-threatening Rare Diseases
Latest action, March 13, 2026: Died in Health Professions & Programs Subcommittee
Authorizes licensed physicians to prescribe & eligible facilities to administer experimental treatments; requires approval of specified platform or master protocol by institutional review board; requires DOH to establish & maintain patient registry; requires DOH to annually publish specified report; encourages health insurers & health maintenance organizations to provide specified insurance coverage for experimental treatments; authorizes licensed physicians & eligible facilities to receive reimbursement for experimental treatments; requires manufacturers of experimental treatments to provide for specified temporary price concession; requires DOH to adopt by rule certain procedures for licensing of experimental treatment centers.
The bill’s record: its number and title, where it stands, its sponsors, every action in its legislature’s words, every version, the roll calls on it, and every change the site recorded, with LegiScan’s license.